ADAP
Adaptimmune Therapeutics Plc
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Adaptimmune Therapeutics PLC (ADAP) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
7 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-03 | 2025-09-02 | Wood Gavin | CFO | Sale | 96,000 | $0.01 | -$960 | N/A | N/A |
| 2025-08-29 | 2025-08-28 | Bertrand William C Jr | COO | Sale | 207,000 | $0.01 | -$2,070 | N/A | N/A |
| 2025-08-19 | 2025-08-18 | Behbahani Ali | Director | Sale | 14,671,794 | $0.01 | -$176,062 | N/A | N/A |
| 2025-08-19 | 2025-08-15 | Behbahani Ali | Director | Sale | 4,828,206 | $0.01 | -$53,110 | N/A | N/A |
| 2025-07-30 | 2025-07-30 | Ecor1 Capital, Llc | 10% Owner | Sale | 27,433,338 | $0.10 | -$2,798,200 | N/A | N/A |
| 2025-07-30 | 2025-07-29 | Ecor1 Capital, Llc | 10% Owner | Sale | 2,687,460 | $0.10 | -$271,433 | N/A | N/A |
| 2025-07-30 | 2025-07-28 | Ecor1 Capital, Llc | 10% Owner | Sale | 33,931,740 | $0.11 | -$3,834,287 | N/A | N/A |